Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
13%
Ph phase_4
2
25%
Ph phase_1
2
25%
Ph phase_3
3
38%

Phase Distribution

2

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Other(2)

Detailed Status

Completed5
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 21 (12.5%)
Phase 33 (37.5%)
Phase 42 (25.0%)

Trials by Status

completed563%
recruiting113%
unknown225%

Recent Activity

1 active trials
Showing 5 of 8
recruitingphase_2

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

NCT05535738
unknownphase_3

Efficacy and Safety of Timolol for TKI Induced Paronychia

NCT06140186
unknownphase_4

Excimer Laser With Topical Agents in Psoriasis Vulgaris

NCT05555797
completedphase_3

Comparative Effect of Nigella Sativa and Conventional Management for OSMF

NCT04476420
completedphase_1

Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034

NCT00358384
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05535738Phase 2

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

Recruiting
NCT06140186Phase 3

Efficacy and Safety of Timolol for TKI Induced Paronychia

Unknown
NCT05555797Phase 4

Excimer Laser With Topical Agents in Psoriasis Vulgaris

Unknown
NCT04476420Phase 3

Comparative Effect of Nigella Sativa and Conventional Management for OSMF

Completed
NCT00358384Phase 1

Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034

Completed
NCT01646567Phase 1

SHP-141C in Plaque Type Psoriasis

Completed
NCT00576550Phase 4

A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema

Completed
NCT00576238Phase 3

Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8